Corbus Pharmaceuticals (CRBP) Insider Trading & Ownership → Don't Pay a Dime for Marc Lichtenfeld's Top AI Picks (From The Oxford Club) (Ad) Free CRBP Stock Alerts $49.92 -2.97 (-5.62%) (As of 02:26 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Corbus Pharmaceuticals (NASDAQ:CRBP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.00%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$33.37 MNumber OfInsiders Selling(Last 12 Months)0 Get CRBP Insider Trade Alerts Want to know when executives and insiders are buying or selling Corbus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRBP Insider Buying and Selling by Quarter Ad The Oxford ClubYour "AI Income Playbook" Awaits...Today, he wants to give you his "AI Income Playbook"... FREE of charge! Inside, you'll discover Marc's favorite AI dividend stocks... Complete with their names, ticker symbols, and full breakdown of their massive income potential.Click here now to claim your FREE copy of Marc's AI playbook. Corbus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/7/2024Cormorant Asset Management, LpMajor ShareholderBuy250,000$40.05$10,012,500.00 2/2/2024Cormorant Asset Management, LpMajor ShareholderBuy750,000$19.00$14,250,000.00 1/26/2024Cormorant Asset Management, LpMajor ShareholderBuy282,632$32.24$9,112,055.68 (Data available from 1/1/2013 forward) CRBP Insider Trading Activity - Frequently Asked Questions Who is on Corbus Pharmaceuticals's Insider Roster? The list of insiders at Corbus Pharmaceuticals includes Cormorant Asset Management, Lp, Craig Stuart Millian, Sean F Moran, and Yuval Cohen. Learn more on insiders at CRBP. What percentage of Corbus Pharmaceuticals stock is owned by insiders? 4.00% of Corbus Pharmaceuticals stock is owned by insiders. Learn more on CRBP's insider holdings. Which Corbus Pharmaceuticals insiders have been buying company stock? The following insiders have purchased CRBP shares in the last 24 months: Cormorant Asset Management, Lp ($33,374,555.68), Craig Stuart Millian ($1,250.00), Sean F Moran ($5,200.00), and Yuval Cohen ($988.00). How much insider buying is happening at Corbus Pharmaceuticals? Insiders have purchased a total of 1,311,432 CRBP shares in the last 24 months for a total of $33,381,993.68 bought. More Insider Trading Tools from MarketBeat Related Companies: Tonix Pharmaceuticals Insider Transactions Lantern Pharma Insider Transactions Orgenesis Insider Transactions Vera Therapeutics Insider Transactions Rocket Pharmaceuticals Insider Transactions Maravai LifeSciences Insider Transactions Amphastar Pharmaceuticals Insider Transactions Protagonist Therapeutics Insider Transactions Zai Lab Insider Transactions Catalyst Pharmaceuticals Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The Top 3 Stocks Sold by Insiders This QuarterTop 4 Stocks With Notable Insider Buying3 Small Cap Tech Stocks That Insiders Are Buying3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks This page (NASDAQ:CRBP) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corbus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.